Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis - a Prospective, Case-controlled Study

NCT07080528 is registered in ClinicalTrials.gov with Tamas Vegh, MD as lead sponsor.

NCT NCT07080528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07080528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis - a Prospective, Case-controlled Study
Lead sponsor
Tamas Vegh, MD
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
July 6, 2024
Completion date
August 30, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade monitoring, neuromuscular blocking agents, residual neuromuscular block